Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonistFederica Cherchi, Anna Maria Pugliese, G Vagnoni et al.|Neuropharmacology|2025Cited by 0
Protection From Demyelination by the Novel Adenosine Dual <scp> A <sub>2A</sub> </scp> / <scp> A <sub>2B</sub> </scp> Receptor Antagonist <scp>P626</scp> in <scp>EAE</scp> and Cultured Oligodendrocyte Precursor CellsMartina Morozzi, Nicoletta Galeotti, Flavia Varano et al.|Journal of Cellular and Molecular Medicine|2025Cited by 0